Montréal, November 20, 2023 —Génome Québec is proud to announce the six research teams that have won major funding under the Genomic Solutions for the Identification, Characterization and Monitoring of Antimicrobial Resistance and Emerging Pathogens program. The total investment, including that of public and private partners, represents over $4.5 million, and will support the development of tools to prepare for future pandemics and counter the threat of antimicrobial resistance.

The response of countries in the early days of the pandemic had a major impact on the health and well-being of citizens, and major social and economic repercussions. The risk of epidemics caused by emerging pathogens is only set to increase. However, the knowledge acquired in recent years in the field of genomic surveillance will enable us to be better prepared for future pandemics. The research projects under this program not only address these concerns, but also help us to act proactively in the face of these imminent challenges.

“Funding such projects is a way to contribute to the creation of innovative solutions in response to the current epidemiological and public health risks in Québec. Genomics can indeed play a central role in understanding and countering antimicrobial resistance and emerging pathogens, notably through the development and creation of diagnostic tools and prevention measures, the development of surveillance capacity and the discovery of new treatments.”

Stéphanie Lord-Fontaine, Vice-President, Scientific Affairs at Génome Québec.

Congratulations to the recipients

What is the Genomic Solutions for the Identification, Characterization and Surveillance of Antimicrobial Resistance and Emerging Pathogens program?

This funding opportunity aims to bring together researchers and stakeholders from different disciplines and sectors to develop innovative genomics solutions that will support:

  • Investigation of infections of unknown etiology
  • Identification and characterization of emerging pathogens and antimicrobial resistance (AMR)
  • Investigation of zoonotic diseases, including surveillance of animal reservoirs
  • Surveillance of pathogens (virus, bacteria, fungi, and parasites) and AMR propagation

Among other things, this program consists of financing projects with a total budget between $300,000 and $800,000 with the contribution of Génome Québec for each approved project ranging from $150,000 to $400,000.

About Génome Québec

Génome Québec’s mission is to catalyze the development and excellence of genomics research and promote its integration and democratization. It is a pillar of the Québec bioeconomy and contributes to Québec’s influence and its social and sustainable development. The funds invested by Génome Québec are provided by the ministère de l’Économie, de l’Innovation et de l’Énergie du Québec (MEIE), the government of Canada, through Genome Canada, and private partners. To learn more, visit


Antoine Gascon                                                                                  

Specialist, Communications and Public affairs                          

Génome Québec                                                                                

514 377-5613